2m 2m 2m 2m 2m 2m 2m
NUVATION BIO-A (NUVB)
NYSE
$4.77-$0.08 (-1.67%)
Price as of Oct 22, 2026 7:30 PM EDT- $1.7BMarket Cap
- 16.87%1-Year Change
- BiotechnologyIndustry
NUVATION BIO-A (NUVB)
$4.77-$0.08 (-1.67%)
NUVB | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $4.85 | ||
Change | +$0.08 (+1.68%) | ||
Open | $4.77 | ||
High | $4.96 | ||
Low | $4.72 | ||
Previous Close | $4.77 | ||
Volume | 4,503,435 | ||
30-Day Average Volume | 5,467,997 | ||
1-Week Change | 3.63% | ||
1-Month Change | -20.10% | ||
1-Year Change | 16.87% | ||
3-Year Change | 314.53% | ||
5-Year Change | -48.40% | ||
Fundamentals | |||
Shares Outstanding | 350.1M | ||
Total Assets | $744.5M | ||
Market Cap | $1.7B | ||
Enterprise Value | $1.7B | ||
Period: QTR TTM FY | |||
Revenue | $23.2M | ||
Net Income | -$62.8M | ||
Free Cash Flow | -$43.2M | ||
EBIT | -$57.7M | ||
EBITDA | -$57.2M | ||
Net Working Capital | $639.7M | ||
EPS | -$0.18 | ||
Enterprise Value/EBITDA | -30 | ||
Enterprise Value/Revenue | 73 | ||
P/B | 7 | ||
P/E | -27 | ||
PEG | 0 | ||
Price/Free Cash Flow | -39 | ||
Price/Operating Cash Flow | -40 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue